CN1118455C - 吡啶二羧酸酯衍生物的制备方法 - Google Patents

吡啶二羧酸酯衍生物的制备方法 Download PDF

Info

Publication number
CN1118455C
CN1118455C CN 98125974 CN98125974A CN1118455C CN 1118455 C CN1118455 C CN 1118455C CN 98125974 CN98125974 CN 98125974 CN 98125974 A CN98125974 A CN 98125974A CN 1118455 C CN1118455 C CN 1118455C
Authority
CN
China
Prior art keywords
general formula
solvent
alkyl
molar equivalent
pyridine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN 98125974
Other languages
English (en)
Other versions
CN1227222A (zh
Inventor
D·Jr·罗伯特
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wyeth Holdings LLC
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Publication of CN1227222A publication Critical patent/CN1227222A/zh
Application granted granted Critical
Publication of CN1118455C publication Critical patent/CN1118455C/zh
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79Acids; Esters
    • C07D213/80Acids; Esters in position 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B43/00Formation or introduction of functional groups containing nitrogen

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pyridine Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

本发明提供了一种制备具有通式I的吡啶二羧酸酯化合物的单罐法,这是通过将烷基乙烯基醚依次与Vilsmeier反试剂、草乙酸酯和氨源缩合而实现的。

Description

吡啶二羧酸酯衍生物的制备方法
吡啶-2,3-二羧酸及酯是许多生物活性产物,尤其是咪唑啉酮除草剂的基本原料,例如美国专利4,758,667。通过氧化合适的喹啉或烷基吡啶前体来制备吡啶-2,3-二羧酸酯衍生物的已知方法常受困于以下因素:使用昂贵的氧化剂,例如KMnO4、H2Cr2O、SeO2等;反应周期长,例如在使用臭氧、电解法等的反应中;不需要的副反应,例如脱羧反应、N-氧化物的形成等。所以,人们一直在寻找一种制备所需的吡啶-2,3-二羧酸酯衍生物的新方法。
已经发现,通过将合适的烷基乙烯基醚依次与Vilsmeier试剂、草乙酸酯和氨源缩合,可以方便地获得一种制备吡啶-2,3-二羧酸酯衍生物的快速单罐法。
本发明提供了一种制备具有通式I的吡啶-2,3-二羧酸酯衍生物的高效方法
Figure C9812597400041
其中,R1是H或可被C1-C4烷氧基或卤素取代的C1-C4烷基;R2和R3各自独立地是C1-C6烷基,优选甲基或乙基。该方法包括:
1)具有通式II的烷基乙烯基醚化合物与至少一摩尔当量的Vilsmeier试剂任选地在第一溶剂中形成第一中间体;
Figure C9812597400042
其中通式II化合物是顺式异构体、反式异构体或其混合物,R是C1-C4烷基,R1的定义与通式I中的相同;
2)所述的第一中间体与至少一摩尔当量的具有通式III的草乙酸酯,在至少2摩尔当量碱存在下形成第二中间体;其中R2和R3的定义与通式I中的相同;
3)第二中间体与氨源任选地在第二溶剂中形成具有通式I的吡啶二酯产物。
通式I化合物可用于制备咪唑啉酮除草剂。
在制备吡啶-2,3-二羧酸酯衍生物的的已知方法中,包括降解法,例如适当取代的喹啉或烷基吡啶前体的氧化。但是,氧化反应过程通常成本高而且危险。可喜的是,已发现,通过将合适的通式II烷基乙烯基醚与Vilsmeier试剂、通式III草乙酸酯和氨源依次缩合,可以在一个反应罐中高效制得吡啶-2,3-二羧酸酯衍生物。该反应如流程图I所示,其中X-表示Cl-或PO2Cl2 -
流程图I
根据本发明的方法,顺式、反式或其混合物形式的通式II烷基乙烯基醚与至少一摩尔当量Vilsmeier反应剂或可性地在第一溶剂中形成第一中间体插烯亚胺盐(vinylogous imidate salt),后者然后与至少一摩尔当量的通式III草乙酸酯在至少二摩尔当量碱(以有机胺碱为佳)存在下形成第二中间体(亚铵盐(iminium salt)),任选地(且是较好的)在第二溶剂中与氨源形成所需的通式I吡啶-2,3-二羧酸酯衍生物。
Vilsmeier试剂在说明书和权利要求书中指二甲基甲酰胺与活化剂(例如草酰氯、碳酰氯、磷酰氯、亚硫酰氯等)原地反应而生成的产物,可以表示为通式IV的亚铵盐或其插烯物,其中X-表示Cl-或PO2Cl2 -
Figure C9812597400061
卤素在说明书和权利要求书中指Cl、Br、I或F。
适合用作本发明第一溶剂的溶剂是任何惰性有机溶剂,例如烃类,如己烷、戊烷、庚烷等;卤化烃,如二氯甲烷、氯仿、二氯乙烷等,以二氯乙烷或二氯甲烷为佳;芳香烃,如苯、甲苯、二甲苯等;卤化芳香烃,如氯苯、邻二氯苯或其混合物。最好,反应在第一溶剂中进行,而且,最好,第一溶剂是卤化烃,例如二氯乙烷或二氯甲烷。
适用于本发明方法的碱是有机胺碱,例如三乙胺、吡啶、二甲基吡啶、N,N-二甲基哌啶、N-甲基吡咯烷酮等,以三乙胺或吡啶为佳。
适用于本发明方法的氨源是任何原地产生NH3的常规方法,其中包括氨气、铵盐等,以铵盐为佳,例如乙酸铵、氨基磺酸铵等。
适合用作本发明中的第二溶剂的溶剂是极性溶剂,例如水;醇,如乙醇、甲醇、丙醇、丁醇之类的C1-C4烷醇等,以乙醇为佳;有机酸,例如乙酸、丙酸之类C1-C4羧酸等,以乙酸为佳,或以上所述物质的混合物。
反应产物的形成速度一般与反应温度成正比。总的说来,低温将减慢反应速度而高温将加速反应。但是,温度不宜过高,这可能降低产品的得率和纯度。较好的温度范围是从0℃至120℃。
为了帮助理解本发明,给出以下实施例,为的是说明某些更具体的细节。本发明并不受实施例的限定,而仅由权利要求限定。NMR表示核磁共振。
                           实施例1
                    吡啶-2,3-二羧酸二乙酯
二甲基甲酰胺(73g,1.00mole)的二氯乙烷溶液在冷却条件下与草酰氯(88ml,1.00mole)缓慢反应,在环境温度下搅拌16小时,与乙基乙烯基醚(72.1g,1.00mole)反应1小时,在环境温度下搅拌16小时。该反应混合物依次与草乙酸二乙酯(199.28g,1.06mole)和(冷却条件下)与三乙胺(224g,2.2mole)反应,搅拌0.5小时,与浓盐酸(200ml)和浓NH4OH(200ml)在100ml水中预混而成的溶液反应。该反应混合物再与水(250ml)、浓NH4OH(70ml)和乙酸(200ml)反应。所得的混合物在N2下,在88℃常压蒸馏去除1850g馏出液。然后用无水乙醇(1.0L)和NH4OCOCH3(180g)处理蒸馏罐,在回流温度加热16小时,并在100℃蒸馏去除887g馏出液。冷却蒸馏罐,将残留物分配在水和2∶1乙酸乙酯/己烷中。分离出有机相,依次用水和盐水洗涤,真空浓缩得到油状标题化合物,179.5g(纯度77%),得率58.5%,用NMR分析鉴定。
                           实施例2-7
使用与实施例1基本相同的方法,使用适当取代的乙烯基醚底物,可得到表I所示的结果。
                                         表I
实施例编号    R       R1          酰氯            碱             Y-                 得率
                                (第一溶剂)     (摩尔当量)     (第二溶剂)              (%)
   2        正丁基    H         草酰氯           三乙胺        -OCOCH3              52.8
                                (ClCH2CH2Cl)  (2.2)          (C2H5OH)
   3        正丁基    H         草酰氯           吡啶          -OCOCH3              39.6
                                (ClCH2CH2Cl)  (2.2)          (C2H5OH)
   4        C2H5   H          POCl3          三乙胺        -OCOCH3              62.3
                                (CH2Cl2)      (3.5)          (C2H5OH)
   5        C2H5   CH3      草酰氯           三乙胺        -SO3NH2             48
                                (CH2Cl2)      (2.5)          (CH3CO2H)
   6        C2H5   C2H5    草酰氯           三乙胺        -OCOCH3              42
                                (CH2Cl2)      (2.5)          (CH3CO2H)
   7        CH3     CH2OCH3  POCl3          三乙胺         OH                     17.7
                                (CH2Cl2)      (3.5)          (H2O/CH3CO2C2H5)1草乙酸二乙酯

Claims (8)

1.制备通式I化合物的方法,其中,R1是H或可被C1-C4烷氧基或卤素取代的C1-C4烷基;R2和R3各自独立地是C1-C6烷基;该方法包括:
a)具有通式II的烷基乙烯基醚化合物与至少一摩尔当量的Vilsmeier试剂任选地在第一溶剂中形成第一中间体;其中通式II化合物是顺式异构体、反式异构体或其混合物,R是C1-C4烷基,R1的定义与通式I中的相同;
b)所述的第一中间体与至少一摩尔当量的具有通式III的草乙酸酯,在至少2摩尔当量碱存在下反应形成第二中间体;
Figure C9812597400023
其中R2和R3的定义与通式I中的相同;
c)第二中间体与氨源任选地在第二溶剂中形成具有通式I的吡啶二酯产物;
以上反应在0-120℃之间进行。
2.根据权利要求1所述的方法,其中存在第一溶剂并且是卤化烃。
3.根据权利要求1所述的方法,其中的碱是三乙胺。
4.根据权利要求1所述的方法,其中存在第二溶剂并且是C1-C4烷基醇或C1-C4羧酸或其混合物。
5.根据权利要求1所述的方法,其中的氨源是乙酸铵。
6.根据权利要求1所述的方法,其中的R1是H、甲基、乙基或甲氧基甲基。
7.根据权利要求6所述的方法,其中的R1是H。
8.根据权利要求1所述的方法,其中的R2和R3各自独立地是甲基或乙基。
CN 98125974 1998-01-28 1998-12-28 吡啶二羧酸酯衍生物的制备方法 Expired - Fee Related CN1118455C (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/014,546 US5892050A (en) 1998-01-28 1998-01-28 Process for the preparation of pyridine dicarboxylate derivatives
US09/014,546 1998-01-28

Publications (2)

Publication Number Publication Date
CN1227222A CN1227222A (zh) 1999-09-01
CN1118455C true CN1118455C (zh) 2003-08-20

Family

ID=21766102

Family Applications (1)

Application Number Title Priority Date Filing Date
CN 98125974 Expired - Fee Related CN1118455C (zh) 1998-01-28 1998-12-28 吡啶二羧酸酯衍生物的制备方法

Country Status (23)

Country Link
US (1) US5892050A (zh)
EP (1) EP0933362B1 (zh)
JP (1) JP4346141B2 (zh)
KR (1) KR100566502B1 (zh)
CN (1) CN1118455C (zh)
AR (1) AR014500A1 (zh)
AT (1) ATE215533T1 (zh)
AU (1) AU756604B2 (zh)
BR (1) BR9900179B1 (zh)
CA (1) CA2260469C (zh)
CZ (1) CZ295307B6 (zh)
DE (1) DE69901130T2 (zh)
DK (1) DK0933362T3 (zh)
ES (1) ES2175899T3 (zh)
HU (1) HUP9900194A1 (zh)
IL (1) IL127853A (zh)
NZ (1) NZ333916A (zh)
PL (1) PL190302B1 (zh)
PT (1) PT933362E (zh)
SG (1) SG74697A1 (zh)
SK (1) SK283297B6 (zh)
TW (1) TW466234B (zh)
ZA (1) ZA99615B (zh)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7032119B2 (en) * 2000-09-27 2006-04-18 Amphus, Inc. Dynamic power and workload management for multi-server system
TW201029975A (en) 2008-11-13 2010-08-16 Basf Se Process for manufacturing substituted 3-pyridylmethyl ammonium bromides
CN102245577B (zh) * 2008-11-13 2014-03-26 巴斯夫欧洲公司 2-[(1-氰基丙基)氨基甲酰基]-5-氯甲基烟酸及其在制备除草咪唑啉酮中的用途
CN102245578B (zh) 2008-11-13 2015-01-07 巴斯夫欧洲公司 制备5-氯甲基-2,3-吡啶二甲酸酐的方法
TWI506019B (zh) 2008-12-08 2015-11-01 Basf Se 製造經取代5-甲氧基甲基吡啶-2,3-二羧酸衍生物之方法
WO2010066668A1 (en) 2008-12-09 2010-06-17 Basf Se Process for manufacturing 5-formyl-pyridine-2,3-dicarboxylic acid esters
CN103724257B (zh) * 2012-10-11 2015-06-10 中国中化股份有限公司 一种制备2,3-二羧酸酯吡啶类化合物的方法
CN104447527B (zh) * 2013-09-23 2017-06-06 中国中化股份有限公司 一种制备吡啶‑2,3‑二羧酸酯化合物的方法
CN107759516B (zh) * 2016-08-16 2021-04-27 沈阳化工研究院有限公司 一种烷基醚取代吡啶-2,3-二羧酸衍生物的制备方法
EP3782985A1 (en) 2019-08-19 2021-02-24 BASF Agrochemical Products B.V. Process for manufacturing 5-methoxymethylpyridine-2,3-dicarboxylic acid derivatives

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4656283A (en) * 1982-05-25 1987-04-07 American Cyanamid Company Alkyl esters of substituted 2-methyl-3-quinolinecarboxylic acid and quinoline-2,3-dicarboxylic acid
US5252538A (en) * 1984-05-21 1993-10-12 American Cyanamid Company (2-imidazolin-2-yl) fused heteropyridine compounds, intermediates for the preparation of and use of said compounds as herbicidal agents
US4723011A (en) * 1985-10-28 1988-02-02 American Cyanamid Company Preparation of substituted and disubstituted-pyridine-2,3-dicarboxylate esters
EP0233150B1 (de) * 1986-02-10 1992-11-11 Ciba-Geigy Ag Verfahren zur Herstellung von 2-(Imidazolin-2-yl)-pyridin- und -chinolin-3-carbonsäuren
JPS62207238A (ja) * 1986-03-07 1987-09-11 Mitsubishi Paper Mills Ltd β−アルコキシアクロレイン誘導体の製造法
EP0296109A3 (de) * 1987-06-18 1989-12-20 Ciba-Geigy Ag 2-(Imidazolin-2-yl)nicotinsäurederivate
DE4025076A1 (de) * 1990-08-08 1992-02-13 Hoechst Ag Verfahren zur herstellung von estern der 5-alkylpyridin-2,3-dicarbonsaeure
DE19501478A1 (de) * 1995-01-19 1996-07-25 Bayer Ag Verfahren zur Herstellung von in 5-Stellung substituierten 2-Chlorpyridinen
US5925764A (en) * 1998-06-15 1999-07-20 Wu; Wen-Xue Process and intermediated for the manufacture of pyridine-2, 3-dicarboxylate compounds

Also Published As

Publication number Publication date
US5892050A (en) 1999-04-06
AU756604B2 (en) 2003-01-16
EP0933362A1 (en) 1999-08-04
TW466234B (en) 2001-12-01
SK10699A3 (en) 1999-08-06
PT933362E (pt) 2002-09-30
BR9900179B1 (pt) 2010-02-09
AU1423599A (en) 1999-08-19
DE69901130D1 (de) 2002-05-08
EP0933362B1 (en) 2002-04-03
CA2260469A1 (en) 1999-07-28
HUP9900194A1 (hu) 2000-03-28
SG74697A1 (en) 2000-08-22
DK0933362T3 (da) 2002-07-01
PL331068A1 (en) 1999-08-02
DE69901130T2 (de) 2002-08-29
ES2175899T3 (es) 2002-11-16
IL127853A0 (en) 1999-10-28
IL127853A (en) 2003-04-10
ATE215533T1 (de) 2002-04-15
NZ333916A (en) 1999-07-29
KR19990068247A (ko) 1999-08-25
BR9900179A (pt) 2000-05-09
ZA99615B (en) 2000-07-27
JP4346141B2 (ja) 2009-10-21
CA2260469C (en) 2008-11-25
JPH11255749A (ja) 1999-09-21
PL190302B1 (pl) 2005-11-30
HU9900194D0 (en) 1999-03-29
CN1227222A (zh) 1999-09-01
SK283297B6 (sk) 2003-05-02
CZ295307B6 (cs) 2005-07-13
AR014500A1 (es) 2001-02-28
CZ23499A3 (cs) 1999-08-11
KR100566502B1 (ko) 2006-03-31

Similar Documents

Publication Publication Date Title
CN1118455C (zh) 吡啶二羧酸酯衍生物的制备方法
CA2060787A1 (en) Production of bisphenol monoester
CN1076191A (zh) 2,3-吡啶二羧酸二烷酯及其衍生物的制备方法
KR890000420A (ko) 3-시아노-4-아릴-피롤의 제조방법
HU910054D0 (en) Process for the production of beta lactames
CN1240683C (zh) 制备2-氨基吡啶及其烷基衍生物的方法
Foot et al. Tandem oxidation processes: The direct conversion of activated alcohols into esters and amides
CN1202075C (zh) 作为抗菌剂喹诺酮药物的有用中间体的3-环丙基氨基-2-[2,4-二溴-3-(二氟甲氧基 )苯甲酰基]-2-丙烯酸烷酯的-锅合成
US5679832A (en) Method for making α,β-unsaturated-β-trifluoromethyl-carboxylates and related compounds
US5274171A (en) Process for the palladium catalyzed coupling of a diazonium salt with an olefinic bond
CN109574873B (zh) 脱氢枞酸基荧光化合物及其制备方法
Rigo et al. Studies on Pyrrolidinones. An Improved One Pot Synthesis of 1, 2, 3, 5, 10, 10a-Hexahydrobenz [f] indolizine-3, 10-dione
Yang et al. A facile and efficient synthetic method for 4-phenylethynylphthalic anhydride
CN1132742A (zh) D-氨基酸-N-(S)-α-烷基苄基酰胺的制备方法
US6545175B1 (en) Ester compounds and their use in forming acrylates
CN1847225A (zh) 一种喹啉类化合物及其制备方法
US4761494A (en) Preparation of cyanomethyl esters
DE4407495A1 (de) Verfahren zur Methylierung organischer Verbindungen
CN115286556A (zh) 一种含有吲哚酮或异喹啉-1,3-二酮结构的酯类化合物的制备方法
US5047545A (en) 2-alkoxycarbonyl-4-(4-pyridyl)cyclohexanones and process for preparing them
IT1315212B1 (it) Impiego di ortoesteri per la sintesi di acidi chirali in processi diesterificazione irreversibili biocatalizzati.
CN1751017A (zh) 取代的邻苯二甲酸酐,特别是4-氯邻苯二甲酸酐的制备
US4451658A (en) Process for producing substituted pyrroles
CN1031571C (zh) 碳代青霉烯衍生物的烯丙基酯的脱保护方法
JPH059171A (ja) 光学活性カルボン酸の蒸留法

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20030820

Termination date: 20161228

CF01 Termination of patent right due to non-payment of annual fee